Single dose dry powder inhaler for asthma and COPD treatments

Increasingly more people are suffering from respiratory issues such as asthma and COPD alongside the accelerating steps of the civilization process and serious air pollution. In order to bring a brighter and healthier future to asthma and COPD patients, BONA has made considerable investment in advanced R&D, resulting in the production of the company's cutting-edge single-dose dry powder inhaler (DPI).

BONA's single-dose DPI is compact and portable, featuring an ergonomic design with easy-breathe technology which makes the product simple to use. The materials are all EP, USP and CP compliant, and the product is produced in a Class 100,000 Clean Room according to GMP regulations.

Features of BONA’s single dose dry powder inhaler (DPI):

• Applicable to capsule 3#
• Ergonomic design, simple to use, easy-breathe technology
• Compact and portable
• Aerodynamic tests can be performed
• Air resistance parameter is equivalent with the device of branded drug
• Materials comply with EP, USP and CP
• Clean Room: Class 100,000 (Class D) according to GMP regulations
• Certificate: CE and US FDA approval
• Customization: color, size and any new design can be customized